February 10, 2012: Cellular, Tissue and Gene Therapies Meeting: Agenda
Meeting, #55, Teleconference
National Institutes of Health, Building 29B, Conference Room A-B
February 10, 2012
|2:00 p.m. (EST)|| Call to Order and Opening Remarks
Conflict of Interest Statement
| Steven Dubinett, M.D., Chair
Designated Federal Officer
|2:10|| Overview - Research Program
Center for Biologics Evaluation
and Research (CBER), FDA
| Carolyn Wilson, Ph.D.
Associate Director for Research, CBER
|2:35|| Overview – Research Programs
Office of Cellular, Tissue and
Gene Therapies, Division of Cellular
and Gene Therapies, CBER, FDA
| Raj Puri, M.D., Ph.D.
Director, Division of Cellular and Gene
|2:50|| Research Highlights – Gene and
Tissue Therapy Branch, Division of
Cellular, Tissue and Gene Therapies
Steven Bauer, Ph.D.
|3:20||Open Public Hearing|